Related Experiment Videos
Rejoinder to "A hybrid phase I-II/III clinical trial design allowing dose reoptimization in phase III"
Andrew G Chapple1, Peter F Thall2
1Biostatistics Program, School of Public Health, Louisiana State University, New Orleans, Louisiana.
Biometrics
|June 28, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing Changes.
Statistics in medicine·2026
The effect of pH on the mechanical properties of beta titanium orthodontic arch wires.
European oral research·2026
Uncertainty-aware registration for probabilistic margin assessment in renal cell carcinoma ablation.
Physics in medicine and biology·2026
FLASH radiotherapy for electrons and protons: roadmap towards the clinical introduction.
Physics in medicine and biology·2026
First attempt of boron neutron capture therapy for adenoid cystic carcinoma liver metastasis: a case report and literature review.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026